PTH-011 Changing Trends of ERCP, a Decade Apart

    loading  Checking for direct PDF access through Ovid



ERCP has become a well established therapeutic intervention. Indications and practice of ERCP have changed over the years due to advent of new imaging modalities. Our aim was to evaluate the ERCP indications, diagnosis and complications over 12month period, a decade apart.


Retrospective observational audit, data extracted from endoscopy reporting system and electronic patient’s records. Consecutive patients undergoing ERCP over 12 months in 2002 and 2012.


Total number of ERCP’s performed was 233 and 212 in the year 2012 and 2002. Median age was 73 and 69 with IQR (58–82) and (56–80) years respectively. Gender ratio in 2012 of 1:1.1 and 1:1.5 in 2002.


Diagnosis: in year 2012: stone disease 109 (46%). Pancreatic Cancer 31 (13.7%). Normal biliary tree 22(9%)whilst in the year In the year 2002 stone disease 90(42%). Pancreatic Cancer 16(7.5%). Normal Biliarytree 60(28%).


Interventions: Year 2012: stent insertion 72(30.9%) and sphincterotomy 155(66.5%). year 2002 stent insertion 39(18.3%) and sphincterotomies 86(40.6%).


Technical success rate in both the years was 95%.


Complications: 30 day mortality in 2012 was 22(9.4%)and 12(5.7%) in 2002. There was one procedure related death in year 2012 (0.4%), none in 2002. Bleeding requiring transfusion : 14(6%) in 2012 6(2.6%) in 2002. Pancreatitis 6(2.6%) and 6(3.3%) in 2012 and 2002. Seven patients required sedation reversal in year 2002 as opposed to 0 in 2012. Reflecting the significantly reduced doses being used in the latter year.


1) Work load remained the same. 2) Less number of normal ERCP’S 3) More pancreatic malignancies identified 4) More therapeutic procedures undertaken.

Disclosure of Interest

None Declared.

Related Topics

    loading  Loading Related Articles